News/ News/ R&D Rome Therapeutics raises $77m for junk DNA-targeting drugs Phil Taylor Biotech, financing, immunology, Oncology, Rome Therapeutics 0 Comment Startup Rome Therapeutics has raised $77 million in second-round financing to help mine sequences of DNA – which Share X Rome Therapeutics raises $77m for junk DNA-targeting drugs https://pharmaphorum.com/news/rome-therapeutics-raises-77m-for-junk-dna-targeting-drugs/
Biotech, financing, immunology, Oncology, Rome Therapeutics
0 Comment
